$MRNA Moderna, Inc. Insider Trading Week 43/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Moderna, Inc. in week 43/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 19.15 | 10,000 | 191,500 | 74,790 | |
| Oct 27 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 5,000 | 61,050 | 220,824 | |
| Oct 27 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 70.99 | 2,100 | 149,079 | 0 | 2.1 K to 0 (-100.00 %) |
| Oct 27 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 70.21 | 6,844 | 480,517 | 2,100 | 8.9 K to 2.1 K (-76.52 %) |
| Oct 27 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 69.42 | 6,056 | 420,408 | 8,944 | 15 K to 8.9 K (-40.37 %) |
| Oct 27 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 19.15 | 10,000 | 191,500 | 15,000 | 5 K to 15 K (+200.00 %) |
| Oct 27 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
| Oct 27 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 70.98 | 600 | 42,588 | 342,442 | 343 K to 342.4 K (-0.17 %) |
| Oct 27 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 70.38 | 5,589 | 393,354 | 343,042 | 348.6 K to 343 K (-1.60 %) |
| Oct 27 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 69.47 | 4,857 | 337,416 | 348,631 | 353.5 K to 348.6 K (-1.37 %) |